Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1968 5
1999 2
2001 1
2002 1
2004 2
2009 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.
Varotto F, Maria GD, Azzaro R, Bellissima P, Amato R, Fogliani V, Muscianisi G, Vitale S, Girbino G, Andò F, Laganà P, Delia S, Jacoviello C, Maierna G, Pezza A, Covelli I, Magrì M, Napoletano G, Rossi A, Marone P, Sanguinetti C, Pela R, Tedeschi D, Viola B, Cicciarella S, Messina G, Rizza S, Fraschini F. Varotto F, et al. Among authors: fogliani v. J Chemother. 2001 Aug;13(4):413-23. doi: 10.1179/joc.2001.13.4.413. J Chemother. 2001. PMID: 11589485
Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing.
Canonica GW, Castellani P, Cazzola M, Fabbri LM, Fogliani V, Mangrella M, Moretti A, Paggiaro P, Sanguinetti CM, Vignola AM; CAST (Control Of Asthma By Symbicort Turbuhaler) Study Group. Canonica GW, et al. Among authors: fogliani v. Pulm Pharmacol Ther. 2004;17(4):239-47. doi: 10.1016/j.pupt.2004.04.006. Pulm Pharmacol Ther. 2004. PMID: 15219269 Clinical Trial.
Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
Bartoloni A, Strohmeyer M, Corti G, Buonomini MI, Franchino L, Romanelli G, Moretti AM, De Vizzi GB, Petraglia A, Mancini P, Atzeni R, Fogliani V, Giura R, Paradisi F. Bartoloni A, et al. Among authors: fogliani v. Drugs Exp Clin Res. 1999;25(6):243-52. Drugs Exp Clin Res. 1999. PMID: 10713862 Clinical Trial.
15 results